Functional improvement in patients with dilated cardiomyopathy after the intracoronary infusion of autologous bone marrow mononuclear cells.

@article{Lezo2013FunctionalII,
  title={Functional improvement in patients with dilated cardiomyopathy after the intracoronary infusion of autologous bone marrow mononuclear cells.},
  author={J. Su{\'a}rez de Lezo and C. Herrera and Miguel Romero and M. Pan and M. D. Carmona and R. Jimenez and Jos{\'e} L. Segura and S. Nogueras and D. Mesa and D. Pavlovic and S. Ojeda and F. Mazuelos and M{\'o}nica Delgado and M. Ru{\'i}z and Mar{\'i}a Luisa Castilla and A. Torres},
  journal={Revista espanola de cardiologia},
  year={2013},
  volume={66 6},
  pages={
          450-7
        }
}
  • J. Suárez de Lezo, C. Herrera, +14 authors A. Torres
  • Published 2013
  • Medicine
  • Revista espanola de cardiologia
  • INTRODUCTION AND OBJECTIVES Different studies have shown improvement in patients with idiopathic nonischemic dilated cardiomyopathy treated with cell-therapy. However, factors influencing responsiveness are not well known. This trial investigates functional changes and factors influencing the 6-month gain in ejection fraction in 27 patients with dilated cardiomiopathy treated with intracoronary cell-therapy. METHODS Patients received intracoronary infusion of autologous bone-marrow… CONTINUE READING
    10 Citations
    Effects of stem cell therapy on dilated cardiomyopathy
    • 2
    Cell therapy, a novel remedy for dilated cardiomyopathy? A systematic review.
    • 33

    References

    SHOWING 1-10 OF 39 REFERENCES
    Intramyocardial Angiogenic Cell Precursors in Nonischemic Dilated Cardiomyopathy
    • 10
    Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review.
    • 541
    • PDF